[Interleukin 18 (IL-18) and other immunological parameters as markers of severity in acute pancreatitis].

Abstract

OBJECTIVE Our aim was to prospectively compare the behavior of interleukin 18 (IL-18) levels and other immunological parameters during the first week of hospitalization between acute pancreatitis patients with and without severity criteria, as well as between patients with and without late pseudocyst development. PATIENTS AND METHODS In 36 patients with acute pancreatis we compared sTNF-RI, IL-1Ra, IL-6, and IL-18 levels at days 1, 2, 3 and 7 after hospitalization between mild pancreatitis, severe pancreatitis, and a "control" group (13 patients) with uncomplicated biliary colic, as well as between patients with and without pseudocyst. RESULTS On comparing mild to severe pancreatitis, IL-18 was significantly higher only the first day in severe pancreatitis, while the other parameters were steadily higher after the second day. In patients developing pseudocyst, IL-18 was also noticeably higher the first day. CONCLUSIONS IL-18 appears to be the earliest marker of complications and severity in acute pancreatitis at both the systemic and local level (pseudocyst).

Statistics

0100200300200920102011201220132014201520162017
Citations per Year

106 Citations

Semantic Scholar estimates that this publication has 106 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Martn2008Interleukin1, title={[Interleukin 18 (IL-18) and other immunological parameters as markers of severity in acute pancreatitis].}, author={M A Mart{\'i}n and E Sarac{\'i}bar and A Santamar{\'i}a and E Arranz and J A Garrote and A Almaraz and M L del Olmo and F Garc{\'i}a-Pajares and P Fern{\'a}ndez-Orcajo and R Velicia and A Blanco-Quir{\'o}s and A Caro-Pat{\'o}n}, journal={Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva}, year={2008}, volume={100 12}, pages={768-73} }